Soru

Zorluk: ZorLabor, Delivery, and Puerperium

A 2626-year-old primigravida at 4040 weeks gestation is evaluated in the labor and delivery unit. She is undergoing an induction of labor for gestational diabetes mellitus. She is currently receiving a continuous intravenous oxytocin infusion, and epidural anesthesia is in place. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, and pulse is 88/min88/\text{min}. A recent cervical examination revealed a dilation of 6 cm6\text{ cm}, 90%90\% effacement, and 00 station. Over the past 2020 minutes, the tocodynamometer records 77 uterine contractions per 1010-minute window, with each contraction lasting 6060 to 8080 seconds. The fetal heart rate tracing demonstrates a baseline of 145/min145/\text{min}, minimal variability, and recurrent decelerations that begin after the peak of the contractions and take ≥30\geq 30 seconds to reach their nadir.

The nurse immediately discontinues the oxytocin infusion, repositions the patient to the left lateral decubitus position, and administers a 500-mL500\text{-mL} intravenous bolus of lactated Ringer solution. Fifteen minutes later, the contraction frequency remains 66 to 77 per 1010 minutes, and the fetal heart rate tracing continues to show recurrent late decelerations with minimal variability.

Which of the following is the most appropriate next step in management?

  1. A
    Proceed to cesarean delivery
  2. B
    Initiate a transcervical amnioinfusion
  3. C
    Perform artificial rupture of membranes
  4. Administer subcutaneous terbutalineCevap
  5. E
    Administer intravenous magnesium sulfate

Cevap

The most appropriate next step is to administer a short-acting tocolytic, such as subcutaneous terbutaline, to relax the uterus and improve fetal oxygenation.
The patient is experiencing uterine tachysystole (>5> 5 contractions in a 1010-minute window) causing uteroplacental insufficiency, indicated by recurrent late decelerations and minimal variability. Initial management involves stopping uterotonic agents, maternal repositioning, and administering an intravenous fluid bolus. If tachysystole and indeterminate or abnormal fetal heart rate changes persist despite these initial resuscitative measures, an acute tocolytic agent (e.g., subcutaneous terbutaline) should be administered to rapidly relax the uterus and restore uteroplacental blood flow.

Adım Adım Çözüm

1
Analyze the contraction and fetal heart rate patterns.
The patient has uterine tachysystole (≥6\geq 6 contractions per 1010 minutes) and a Category II fetal heart rate tracing characterized by minimal variability and recurrent late decelerations.
Identifying the complication is essential; excessive contractions are causing uteroplacental insufficiency.
2
Evaluate the response to initial management.
Standard initial resuscitative measures (stopping oxytocin, maternal repositioning, and IV fluids) were correctly implemented but failed to resolve the tachysystole or the fetal heart rate abnormalities after 1515 minutes.
If initial non-pharmacologic measures and cessation of uterotonics fail, the algorithm must be escalated to active medical intervention.
3
Determine the next pharmacological step before surgical intervention.
Administration of an acute tocolytic agent (beta-2 agonist) is indicated to rapidly decrease uterine activity.
Tocolysis can restore normal uteroplacental blood flow and improve the fetal heart rate, potentially avoiding an emergent cesarean delivery.

Anahtar Kavram

Persistent uterine tachysystole with abnormal fetal heart rate changes that do not respond to initial resuscitative measures (stopping uterotonics, maternal repositioning, fluid bolus) should be managed with an acute tocolytic agent such as terbutaline.
Tahmini Süre:1m 30s
Bu soruyu puanla